Senate Finance Committee investigating J&J
Executive Summary
The Senate Finance Committee is seeking information from Johnson & Johnson on medical education activities the company funded for its heartburn drug Propulsid (cisapride). A July 5 letter to the company from committee Chairman Charles Grassley (R-Iowa) and Ranking Member Max Baucus (D-Mont.) cites a June New York Times article discussing promotion of Propulsid's use in children before the company ceased marketing the product in 2000. The committee asks J&J to identify specific dollar amounts for educational grants and employees responsible for those grants between 1993 and 2000...